Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Alexithymia in Neurological Disease: A Review.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Voice-related quality of life in patients with multiple sclerosis.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Future MRI tools in multiple sclerosis.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules.
Disease-modifying therapies and infectious risks in multiple sclerosis.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
Mimics and rare presentations of pediatric demyelination.
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.

Pages